, pigs (Simmen et al., 1991) , cows (Geisert et al., 1991; Robinson et al., 2000) and sheep (Stevenson et al., 1994) , and the oviduct in humans (Giudice et al., 1992) , cows (Schmidt et al., 1994; Winger et al., 1997) , sheep (Stevenson and Wathes, 1996) and pigs (Wiseman et al., 1992) . A particular feature of the IGF system is that the production of many of its components can be regulated by nutrition (McGuire et al., 1992; Roberts et al., 1997) . This finding raises the possibility that metabolic status could alter oviductal activity via modulation of the IGF system.
Studies in vitro have shown that the oviduct contains a number of growth factors that can stimulate cellular proliferation and differentiation of preimplantation embryos (for a review, see Heyner, 1997) . These factors include members of the epidermal growth factor (EGF) and transforming growth factor β (TGFβ) families (Dalton et al., 1994; Zhao et al., 1994) in addition to the IGFs and their binding proteins. Several lines of evidence indicate a role for the IGFs in the preimplantation period. The anabolic and mitogenic influences of IGF-I on murine preimplantation development are well characterized (Kaye et al., 1992) . Studies have indicated that IGF-I exerts a beneficial effect on the development of early pig embryos in vitro (Xia et al., 1994) . However, results from bovine studies are not as clear. Although some studies indicate that IGF-I has little influence on developmental frequencies (Larson et al., 1992) , other studies report dose-responsive influences on development of bovine zygotes to the blastocyst stage (Herrler et al., 1993; Palma et al., 1997) .
According to this evidence, it is clear that the oviducts of various species including cattle express transcripts for IGF ligands, IGF-1R and IGFBPs. However, there have been no detailed studies to determine the sites of expression or to examine the effects of factors, such as pregnancy or stage of the oestrous cycle, on the IGF system in the bovine oviduct. Studies in this area are potentially important because of the high incidence of early embryo mortality in this species (Wathes, 1982) . Therefore, the objectives of the present investigation were to localize and characterize the spatial and temporal expression patterns for IGF-I, IGF-II, IGF-1R and IGFBPs (-1, -3 and -5) in the bovine oviduct at oestrus and during early pregnancy.
Materials and Methods

Animals and management
Sixty-six nulliparous Simmental ϫ Holstein/Friesian heifers (study A) and ten multiparous mid-lactation Holstein/ Friesian dairy cows (study B) were used in this study. Samples from both studies were analysed together at the same time. All experiments were conducted under the Animals (Scientific Procedures) Act 1986.
In both studies, tissue was collected on specified days of the oestrous cycle after a synchronization regimen. For the heifers in study A, the regimen started on day 1 with the insertion of a controlled internal drug releasing (CIDR) device (1.9 g progesterone intra-vagina; SmithKlineBeecham Animal Health, Tadworth). On day 6, each heifer was injected i.m. with 500 µg prostaglandin (Estrumate; Coopers Animal Health, Crewe, Cheshire). The CIDR device was removed 5 days after the prostaglandin injection (day 11). A second dose of prostaglandin was administered 15 days later (day 27) and the heifers were given timed artificial inseminations (AI) twice at 72 and 90 h after the second prostaglandin injection. The heifers were killed on day 3 (n = 25), day 6 (n = 24) or day 16 (n = 17) after AI and the reproductive tracts (the oviduct, uterus or both, depending on the day the heifers were killed) were flushed with normal saline to determine the presence of viable embryos. Oviducts were then coiled and frozen in liquid nitrogen. Once frozen, the oviducts were wrapped in aluminium foil, transported to the laboratory in dry ice and stored at -80ЊC.
The mature cows in study B were synchronized by i.m. administration of 500 µg prostaglandin in the mid-luteal phase of the oestrous cycle, which was monitored using milk progesterone radioimmunoassay (Bulman and Lamming, 1978) . The cows were killed when signs of oestrus were observed (day 0, n = 6) or on the day after observed oestrus (day 1, n = 4). Ovaries of the day 0 cows contained preovulatory follicles, whereas the ovaries from the day 1 cows showed a recent ovulation point. Oviducts ipsilateral to the preovulatory follicle or corpus haemorrhagicum were collected and processed as above.
Oligonucleotide probes
All probes used were single-stranded oligonucleotides (Babraham Institute, Cambridge) (for details see Table 2 ). The probes used have been validated previously for use in cows (Robinson et al., 2000) . Sense probes were always included as negative controls and any signals from these probes were regarded as non-specific.
Localization of mRNA by in situ hybridization
The in situ hybridization technique was performed as described by Stevenson et al. (1994) and Robinson et al. (2000) . Briefly, sections were fixed in 4% (w/v) paraformaldehyde, dehydrated in ethanol and stored at 4ЊC in ethanol. The oligonucleotide (5 ng) was end-labelled with [ 35 S]dATP (Promega UK, Delta House, Chilworth Research Centre, Southampton) using deoxynucleotidyl transferase (Pharmacia Biotech, St Albans, Herts). A labelled probe (100 µl, diluted to a final concentration of 1 100 000 c.p.m. ml -1 ) was added to each section and incubated at 42.5ЊC overnight. The following day, the slides were washed, airdried and exposed to β-max hyperfilm (Amersham International, Amersham, Bucks) for 14, 18 or 24 days (Table 1) .
Photographic emulsions
Slides exposed previously to X-ray film were coated with photographic emulsions LM1 (Amersham International) according to the manufacturer's instructions and kept at 4ЊC for 21, 24 or 36 days ( Table 1 ). The slides were developed in 20% (v/v) phenisol, fixed in 1.9 mol sodium thiosulphate l -1 and counterstained with haematoxylin and eosin to confirm cellular localization of the radioactivity.
Absorbance measurements
Absorbance units were measured from autoradiographs for the mucosa and muscle layers for each of the three oviductal regions: infundibulum, ampulla and isthmus, although the infundibulum was not present in all sections. Measurements were made using a Seescan image analysis system (Seescan plc, Cambridge) as described by Stevenson et al. (1994) . In brief, autoradiographs were projected on to a computer screen; the region of interest was encircled and the mean absorbance reading of this area was measured. The background absorbance, from a blank autoradiograph, was first subtracted automatically. The absorbance value for the sense section was subtracted from the corresponding antisense section. Readings were obtained from four sections per cow and a mean value of specific hybridization for each animal was calculated. The limit of detection was taken as an absorbance value of 0.01. The intra-assay coefficients of variation (based on duplicate slides using the same probe) for the probes studied were as follows: IGF-I, 5.6%; IGF-II, 7.2%; IGF-1R, 6.8%; IGFBP-3, 5.7%; and IGFBP-3, 3.6%. Sections for a particular probe, from both studies, were all analysed in a single assay to avoid any interassay variations. 
Statistical analysis
Statistical analysis was performed using SPSS (version 9). Data were checked for homogeneity of variance using Levene's test and log transformed if appropriate. Initial analysis of the data on the heifers (study A) was performed using GLM multivariate ANOVA (MANOVA) with day 3, 6 or 16 after AI and presence or absence of embryos as factors. The data on the cows (study B) were initially analysed by one-way ANOVA to compare the results on day 0 with day 1. Finally, the data on the heifers from day 3, day 6 and day 16 and the data on the cows from day 0 and day 1 were analysed together using one-way ANOVA to detect whether the expression pattern changed according to the day after oestrus. Where significance was demonstrated, differences between days were tested using LSD.
Results
In study A, the data for the number of heifers with an embryo present on each day were as follows: day 3 (14/25), day 6 (12/24) and day 16 (12/17). Data on each of these days were analysed according to the presence or absence of a viable embryo in the fluid used to flush the reproductive tract. No differences in the absorbance readings were detected in any particular oviductal region for any of the probes examined on any of the days. Therefore, on each of the three days, data were pooled from heifers with and without an embryo. These results are considered below together with those from the multiparous cows. Data on the infundibulum have not been included in the tables as fewer sections were examined, so quantification was less reliable.
Distribution of IGF-I mRNA IGF-I mRNA was present in the mucosa and muscle of all three regions examined (Fig. 1a) . Cellular localization of the signal using emulsion-coated slides showed that the IGF-I gene transcripts were localized mainly to the stromal fibroblast underlying the luminal epithelium in the mucosa and to the smooth muscle cells of the muscle wall in both the ampulla and isthmus (Fig. 2a) . Expression of IGF-I mRNA in the heifers varied according to the days after AI and the highest expression was observed on day 3 (Table 2) , particularly in the muscle layer. The values recorded in the mucosa of cows on day 0 and day 1 were similar to those found in heifers on day 3, whereas concentrations in the muscle were lower (P < 0.05) and equivalent to those found in heifers on day 6 (Table 3) .
Distribution of IGF-II mRNA
The transcripts for IGF-II mRNA showed strongest hybridization to the smooth muscle cells of the muscle wall of both the ampulla and isthmus (Fig. 1c) . However, transcripts were barely detectable in the mucosa of both regions. Expression of IGF-II mRNA in the muscle wall was low and did not vary according to the days after AI, so values were pooled. The overall absorbance values in the muscle layer of the ampulla were: heifers, 0.03 Ϯ 0.002 (n = 64) and cows, 0.03 Ϯ 0.004 (n = 10). The equivalent values in the muscular wall of the isthmus were 0.04 Ϯ 0.003 and 0.04 Ϯ 0.005, respectively.
Distribution of IGF-1R mRNA IGF-1R mRNA was present in both the muscle and mucosa of all three oviductal regions (Fig. 1e) . In the heifers, there was a trend for higher expression on day 16 after AI (Table 2) . Absorbance values measured in cows on day 0 and day 1 were in the same range as those in the heifers (Table 3) .
Distribution of IGFBP-1 mRNA IGFBP-1 mRNA transcripts were not detectable in any of the regions at any time point studied.
Distribution of IGFBP-3 mRNA
Transcripts encoding IGFBP-3 mRNA were detectable in all three oviductal regions tested (Fig. 3) . Emulsion-coated slides counterstained with haematoxylin and eosin showed that the IGFBP-3 gene transcripts in the ampulla and isthmus were localized mainly to the luminal epithelium and to the smooth muscle cells (Fig. 2b,c) , whereas in the infundibulum the localization was primarily to the subepithelial stroma underlying the luminal epithelium and to the muscle wall.
In both heifers and cows, the strongest expression of IGFBP-3 was observed in the mucosa of the isthmus (Tables  3 and 4 ). In heifers, there were no differences in expression on the different days studied. In cows, values were similar on day 0 and day 1. However, a comparison of heifers and cows in relation to the day after oestrus showed consistently higher expression in cows on day 0 and day 1 than in heifers on day 3, day 6 and day 16 in all regions (P < 0.01).
Distribution of IGFBP-5 mRNA
All three oviductal regions expressed transcripts for IGFBP-5 mRNA (Fig. 3) . The strongest hybridization was observed in the muscular layer of both the ampulla and isthmus (Tables 3 and 4 ). In heifers, IGFBP-5 expression reached a peak on day 6 after AI in comparison with day 3 and day 16 (Table 4 ). There was a tendency for IGFBP-5 expression to be higher in cows than heifers, but this difference was less pronounced than for IGFBP-3.
Discussion
The present study has provided novel data on the localization of the IGF system within different regions of the oviduct in relation to the time of fertilization and the success of early embryonic development. Patterns of localization were very similar between the non-lactating beef cross heifers in study A and lactating dairy cows in study B, and so the two studies are discussed together.
IGF-I gene transcripts in all three oviductal regions were localized mainly to stromal fibroblasts underlying the luminal epithelium in the mucosa and also to the smooth muscle cells of the muscle wall. Previous studies have reported peak expression of IGF-I mRNA in the oviduct near the time of oestrus (bovine, Schmidt et al., 1994; ovine, Stevenson and Wathes, 1996) and the results of the present study are consistent with these reports. Whereas in situ hybridization studies show highest expression in the stroma (present study; Stevenson and Wathes, 1996) , Schmidt et al. (1994) and Xia et al. (1996) both reported that IGF-I protein was localized mainly in the epithelial secretory cells. This finding may indicate that the IGF-I detected by immunocytochemistry was attached to a binding protein or receptor, and the results of the present study indicate that binding to IGFBP-3 would be a possibility. The increase in IGF-I gene transcripts near the time of ovulation and in the early luteal phase supports the concept that ovarian oestradiol regulates the expression of IGF-I in the oviduct, as suggested previously for the oviduct of rats (Carlsson et al., 1993) , and the uterus in sheep (Stevenson et al., 1994) , cattle (Robinson et al., 2000) and pigs (Simmen et al., 1991) . As pre-attachment bovine embryos express gene transcripts encoding the type 1 receptor throughout the first week of development (Watson et al., 1992 (Watson et al., , 1994 , IGF-I secreted into oviductal fluid could act as a paracrine regulator of early embryonic cleavage.
The principal site of IGF-II gene transcription was the smooth muscle cells of the muscle wall, whereas IGF-II transcripts were barely detectable in the mucosa of any of the regions examined. The presence of IGF-II mRNA in the oviductal tissue confirms the results of two studies using rtPCR (Kincy et al., 1992; Xia et al., 1996) and the low expression is also in agreement with previous work in ruminants (Stevenson and Wathes, 1996; Xia et al., 1996) . On the basis of these observations, it is hard to be persuaded that bovine oviduct cultures release ten times more IGF-II than IGF-I as reported by Winger et al. (1997) . The increased content of IGF-II peptide measured in pig oviducts collected during oestrus (Wiseman et al., 1992) could therefore be attributable to increased transudate from The distribution of IGF-1R in both the mucosa and muscle of the bovine oviduct was similar to that described for sheep (Stevenson and Wathes, 1996) . The IGF-1R in the mucosa may participate in the increased secretory activity of the epithelial cells that occurs during oestrus and the early luteal phase in various species (Wiseman et al., 1992; Murray, 1996; Makarevich and Sirotkin, 1997) , whereas the IGF-1R in the muscle may contribute to the enhanced contractility of the oviduct at oestrus (Ruckebusch and Bayard, 1975; Gilbert et al., 1992) . Makarevich and Sirotkin (1997) also demonstrated that both growth hormone and IGF-I stimulated cAMP production by cultured bovine oviductal cells, whereas PGF 2α release was inhibited.
In the present study, it was demonstrated that the bovine oviduct expresses IGFBP-3 and -5 mRNAs, whereas IGFBP-1 mRNA was not detected at any of the time points investigated. These results are in agreement with observations for bovine oviduct cultures (Winger et al., 1997) . The strongest expression of IGFBP-3 mRNA was in the epithelial lining of the isthmus during oestrus. The localization was similar in the ampulla, although the concentration was lower, whereas in the infundibulum, expression of IGFBP-3 mRNA was predominantly in the sub-epithelial stroma of the mucus membrane. These observations indicate both that there may be region-specific expression of IGFBP-3 and that this binding protein may help to regulate the concentration of IGF-I in the oviductal fluid. This pattern of distribution might help to create an IGF-I gradient along the oviduct as the embryo travels through it.
In the present study, expression of IGFBP-3 mRNA was markedly higher in the samples collected from cows at oestrus and on day 1 compared with the luteal phase samples obtained from the heifers on day 3, day 6 and day 16 after AI. Peak expression of IGFBP-3 mRNA at oestrus is also in agreement with the situation reported previously in the ovine oviduct (Stevenson and Wathes, 1996) , indicating that the variation was due to the stage of the oestrous cycle or pregnancy rather than to the type of cow. However, studies on the bovine uterus did not show an effect of the stage of oestrous cycle, but there were differences in the expression pattern of IGFBP-3 mRNA in endometrial biopsy samples obtained during the luteal phase from two groups of cows, indicating that the difference might be related to the lactational or nutritional status of the animals (Robinson et al., 2000) . The actions of IGFBP-3 on IGF-I are generally inhibitory, although potentiating effects have also been described (for reviews, see Rechler, 1993; Rechler and Clemmons, 1998) . If expression of IGFBP-3 mRNA in the uterus and oviduct of cows is indeed regulated by nutrition, it is possible that increased concentrations of IGFBP-3 may be present in early lactation when dairy cows are in negative energy balance (Beam and Butler, 1999) and that this could inhibit actions of IGF-I on the reproductive tract. This suggestion cannot be resolved from the present set of data and warrants further investigation.
During the oestrous cycle, IGFBP-5 mRNA was localized predominantly to the smooth muscle cells in both the ampulla and isthmus. Similarly, Winger et al. (1997) reported that primary cultures of bovine oviduct expressed IGFBP-5 mRNA throughout an 8 day culture period and that oviductal monolayers and vesicular cultures released IGFBP-5. In the ovine uterus, IGFBP-5 concentrations were highest in the luminal epithelium and caruncular stroma, with moderate to low expression in the inner myometrium and endometrial stroma, respectively (Gadd et al., 2000) . The reason for the increased expression in the heifers on day 6 after AI is uncertain.
Several studies on cows have investigated the relationship between the uterine IGF system and the establishment of pregnancy (Geisert et al., 1991; Kirby et al., 1996; Keller et al., 1998; Robinson et al., 2000) . Although the results expressed strongly in the mucosa, whereas IGFBP-5 mRNA was expressed predominantly in the smooth muscle of the oviduct. Scale bars represent 500 µm. *Samples were collected from six cows on the day of oestrus (day 0) and from four cows on the following day (post ovulation, day 1). There were no significant differences between these two time points. IGF-1R: type 1 IGF receptor; IGFBP: IGF binding protein.
were not entirely consistent, there was a trend towards higher expression of IGF-I and IGFBP-1 mRNA and lower amounts of IGFBP-2 and -3 mRNA in the uteri of pregnant compared with non-pregnant cows in the late luteal phase (days 16-17) . This finding may indicate that cows in better nutritional status have an increased likelihood of establishing a pregnancy or that there is a local effect of the embryo on the IGF system. In the present study, there was no observed effect on the oviductal IGF system associated with the presence or absence of an embryo. However, it is possible that an effect of nutrition could influence the suitability of the oviduct for early embryo development via alterations in circulating IGF-I (Breier et al., 1988; McGuire et al., 1992) .
In conclusion, the present study has illustrated the spatial and temporal distribution of the IGF system in the bovine oviduct. Locally or systemically produced IGF-I may regulate embryo development directly (via secretion into the oviductal lumen) and indirectly (via actions on the IGF-1R present on the mucosal secretory cells). As mRNAs encoding IGF-I and -II and IGF-1R were all present in the muscle wall, local production of these peptides may modulate the muscular contractility of the oviduct. The contraction of the oviduct could in turn affect the movement of the egg, spermatozoa and embryo. The presence of IGFBP-3 and -5 may regulate the transfer of IGFs into the oviductal lumen and influence the action of IGFs on the oviduct mucosa and musculature. 
